Industry analysts from McKinsey to Omdia largely converge on a timeline for initial quantum advantage emerging in the next few years. While the era when quantum computers can routinely tackle large-scale challenges in fields like drug discovery and materials science might still be years away, IBM’s Quantum CTO, Oliver Dial, Ph.D., predicts the threshold of…